Skip to main content
. 2023 Nov 1;20(11):1633–1641. doi: 10.1513/AnnalsATS.202303-248OC

Table 1.

Summary of participant characteristics

Characteristic Value n
Age, yr 63.2 ± 11.3 5,655
Race    
 White 4,781 (84.5%) 5,655
 Black 504 (8.9%)
 Other 370 (6.6%)
Sex    
 Male 2,666 (47.1%) 5,655
 Female 2,989 (52.9%)
Body mass index, kg/m2 28.1 ± 5.0 5,615
Smoking    
 Never 2,644 (46.7%) 5,616
 Current 549 (9.7%)
 Former 2,423 (42.8%)
Diabetes 392 (6.9%) 5,393
History of COPD 62 (1.1%) 5,599
EDS 1,335 (24.5%) 5,441
Hypertension* 2,384 (42.5%) 5,655
Apnea–Hypopnea Index 12.9 (6.7–23.2) 5,655
T90 0.18 (0.0–1.7) 5,650
Wakefulness SpO2 97.3 (96.1–98.0) 5,655
HB, % min/h 34.4 (18.4–59.8) 5,655
HBOxi, % min/h 34.5 (21.7–53.8) 5,655

Definition of abbreviations: COPD = chronic obstructive pulmonary disease; EDS = excessive daytime sleepiness (Epworth Sleepiness Scale score >10); HBOxi = oximetry-derived hypoxic burden; SpO2 = oxygen saturation as measured by pulse oximetry; T90 = total time arterial oxygen saturation is <90%.

Data presented as mean ± standard deviation for continuous variables. Ranges in parentheses are interquartile ranges.

*

Hypertension status was defined based on the average of the second and third sitting blood pressure readings of >140 mm Hg in systolic blood pressure and >90 mm Hg in diastolic blood pressure or being treated with hypertension medications.

All apneas and hypopneas with ⩾30% nasal cannula reduction and ⩾3% oxygen desaturation or with arousal per hour of sleep.

Wakefulness SpO2 was the average of local SpO2 maxima during the wakefulness period before the start of the first sleep period.